Skip to main content
OpenTrials

Clinical trial condition

Hemophilia A

Explore clinical trials studying Hemophilia A. Study availability and eligibility vary by location and protocol.

600 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Hemophilia A trial results

Completed

A Study to Evaluate the Pharmacokinetics，Safety and Tolerability of PEG Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection

NCT04864743

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations
  • Nanfang Hospital of Southern Medical University Guangzhou, China
  • People's Hospital of Zhengzhou Zhengzhou, Henan, China
  • Jinan central hospital Jinan, Shandong, China
  • Institute of Hematology & Blood Diseases Hospital Chinese Academy of Medical Sciences & Peking Union Medical College. Tianjin, Tianjin Municipality, China
View Trial Details
Completed

Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care

NCT01431326

Conditions
Adenoviridae Infections, Adenovirus, Adrenal Gland Diseases, +162 more
Locations
  • Alaska Native Medical Center Anchorage, Alaska, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • University of California at San Diego Medical Center La Jolla, California, United States
  • Axis Clinical Trials Los Angeles, California, United States
View all 52 locations
View Trial Details
Completed

Genetic Factors of the Desmopressin Response in Carriers of Hemophilia A

NCT06020456

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Carrier of Hemophilia A, +9 more
Locations
  • University hospital of Bordeaux Bordeaux, France
  • University hospital of Brest Brest, France
  • Hospices civils de Lyon Bron, France
  • University hospital of Dijon Dijon, France
View Trial Details
Completed

Phase III Expansion Trial for Determining the Safety and Efficacy of Recombinant Human Coagulation Factor VIII-Fc Fusion Protein for Injection in Adolescent and Adult Patients With Hemophilia A

NCT04845399

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • Capital Medical University affiliated Beijing Children's Hospital Beijing, Beijing Municipality, China
  • Chongqing Three Gorges Central Hospital Chongqing, Chongqing Municipality, China
  • The First Hospital of Lanzhou University Lanzhou, Gansu, China
View all 16 locations
View Trial Details
Completed

A Study to Evaluate the Safety and Pharmacokinetic of Recombinant Human Coagulation Factor VIII ，Fc Fusion Protein for Injection

NCT05251090

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • Beijing Children's Hospital,Capital Medical University Beijing, Beijing Municipality, China
  • Shenzhen Children's Hospita Shenzhen, Guangdong, China
  • Nanfang Hospital of Southern Medical University Guangzhou, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology Wuhan, Hubei, China
View Trial Details
Completed

Study to Gain More Information on How Safe and Effective Jivi Works in Patients With Severe Hemophilia A (Post-marketing Investigation)

NCT04085458

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • UMHAT Tsaritsa Joanna-ISUL EAD Sofia Sofia, Bulgaria
  • MHAT Sveta Marina EAD Varna, Bulgaria
  • Aarhus Universitetshospital, Skejby Arhus N, Denmark
  • LAIKO General Hospital of Athens Athens, Greece
View all 13 locations
View Trial Details
Completed

A Study of Standard and Individualized Prophylactic Treatment With Advate in Men and Boys With Severe Hemophilia A

NCT04953000

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations
  • City Children's Hospital No. 1 Kazan', Tatarstan Republic, Russia
  • Chelyabinsk Regional Children's Clinical Hospital Chelyabinsk, Russia
  • Children's Regional Clinical Hospital Khabarovsk, Russia
  • Krasnoyarsk Regional Clinical Center for Maternal and Child Health Krasnoyarsk, Russia
View all 13 locations
View Trial Details
Completed

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

NCT03876301

Conditions
Blood Coagulation Disorder, Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, +9 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • University of Florida Gainesville, Florida, United States
  • Emory University Atlanta, Georgia, United States
  • Children's Hospital of Michigan Detroit, Michigan, United States
View Trial Details

Related conditions